Published in Clin Exp Immunol on March 01, 1984
Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: in vitro characterization and time course study. Clin Exp Immunol (1988) 0.78
Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients. J Clin Invest (1987) 0.75
Immunoassay of endogenous plasma insulin in man. J Clin Invest (1960) 25.67
Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63
Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology (1968) 11.20
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol (1979) 6.08
Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes (1965) 6.00
Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (1974) 5.59
Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science (1979) 1.87
Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med (1978) 1.59
Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med (1980) 1.59
Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet (1974) 1.57
Evidence for a primary autoimmune type of diabetes mellitus. Br Med J (1978) 1.55
Classification of idiopathic diabetes. Lancet (1977) 1.52
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43
Preparation of single cells from pancreatic islets of adult rat by the use of dispase. Endocrinol Jpn (1977) 1.17
In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon. J Immunol (1982) 1.14
Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells. J Clin Invest (1982) 1.10
Animal models of diabetes. Am J Med (1981) 1.07
Insulin-dependent diabetes: a disease of autoaggression. Science (1976) 1.07
Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia (1981) 0.99
Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J Clin Invest (1981) 0.97
Islet cell antibodies-theoretical and practical implications. Diabetologia (1981) 0.97
Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients. Diabetes (1980) 0.92
Complement-fixing Islet cell antibodies from some diabetic patients alter insulin release in vitro. Diabetes (1981) 0.87
Cytotoxic T lymphocytes induced by syngeneic mouse melanoma cells recognize human melanomas. Nature (1981) 0.86
Islet-cell antibodies (ICA) in diabetes mellitus (evidence of an autoantigen common to all cells in the islet of Langerhans). Ric Clin Lab (1978) 0.84
Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med (1987) 4.38
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet (2001) 3.50
Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica. Nature (1966) 3.17
Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet (1993) 2.56
Effect of glucose on plasma glucagon, growth hormone, and insulin in exchange transfusion. Arch Dis Child (1972) 2.13
Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet (1986) 2.10
Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia (1977) 2.08
Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. Lancet (2000) 2.07
Structure-function and structure-immunoreactivity relationships of the glucagon molecule and related synthetic peptides. Diabetes (1972) 2.03
Fuels, hormones, and liver metabolism at term and during the early postnatal period in the rat. J Clin Invest (1973) 2.03
A severe reaction to carbamazepine: consequences for patient monitoring. Br Dent J (1998) 2.02
Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci U S A (2006) 1.85
Diabetes mellitus after abdominal radiation therapy. Lancet (1995) 1.79
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.63
Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum (2001) 1.59
Persistent Schistosoma mansoni infection in Yemeni immigrants to Israel. Isr J Med Sci (1990) 1.57
Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes (1990) 1.57
A reappraisal of the concept of organ "rejection," based on the study of homotransplanted kidneys. Transplantation (1967) 1.56
Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med (1988) 1.47
Behçet's syndrome: a multidisciplinary approach to clinical care. QJM (1999) 1.44
Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis (2008) 1.42
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients. Diabetes Care (1995) 1.40
[Prediction and prevention of type 1 diabetes]. Arch Fr Pediatr (1992) 1.38
Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients. Diabetes Care (1994) 1.38
Correlation between mixed lymphocyte culture performed before renal transplantation and kidney function. Clin Exp Immunol (1970) 1.32
Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol (2004) 1.31
[Evolution of hormonal parameters (glucagon, cortisol, growth hormone) and energetic parameters (glucose, fatty acids, free glycerol) in 10 severe cases of diabetic acido-ketosis under treatment]. Pathol Biol (Paris) (1969) 1.24
High-resolution linkage mapping for susceptibility genes in human polygenic disease: insulin-dependent diabetes mellitus and chromosome 11q. Am J Hum Genet (1991) 1.23
Glucagon secretion during the early postnatal period in the rat. Horm Metab Res (1972) 1.22
Serologic factors in human transplantation. Ann Surg (1967) 1.22
Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine synthesis. J Exp Med (1981) 1.22
Antibody-mediated elimination of malaria parasites (plasmodium berghei) in vivo. Infect Immun (1975) 1.21
Oral mucosal lichen planus in children. Int J Paediatr Dent (2001) 1.21
Schistosoma mansoni soluble egg antigens. I. Identification and purification of three major antigens, and the employment of radioimmunoassay for their further characterization. J Immunol (1976) 1.21
[A new metabolic disease: the complete deficit of adenine phosphoribosyltransferase and lithiasis of 2,8-dihydroxyadenine]. C R Acad Sci Hebd Seances Acad Sci D (1974) 1.20
Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol (1988) 1.19
Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL-14. Eur J Immunol (1994) 1.18
T and B cell population changes in young and in adult rats infected with Plasmodium berghei. Infect Immun (1976) 1.18
Plasmodium berghei: use of free blood stage parasites to demonstrate protective humoral activity in the serum of recovered rats. Exp Parasitol (1976) 1.17
Factors affecting the secretion of insulin and glucagon by the rat fetus. Diabetes (1974) 1.16
Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats. Diabetologia (1995) 1.15
In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon. J Immunol (1982) 1.14
Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int (1990) 1.13
Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet (1985) 1.13
[The effects of perfusion and amino acid ingestion in glucagonenemia]. Journ Annu Diabetol Hotel Dieu (1967) 1.11
Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol (1991) 1.09
Glucagon, insulin, and growth hormone response to exchange transfusion in premature and term infants. Arch Dis Child (1972) 1.07
[Preliminary note on the apparently better tolerance of renal allografts by recipients bearing the histocompatibility HL-A 1 antigen]. C R Acad Sci Hebd Seances Acad Sci D (1971) 1.06
Serial postprandial plasma insulin levels in 117 subjects with and without diabetes. Diabetes (1973) 1.06
Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J Exp Med (1995) 1.05
In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products. Proc Natl Acad Sci U S A (1985) 1.04
The immunological follow up of renal allograft recipients. Proc R Soc Med (1972) 1.03
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients. Diabetologia (2012) 1.03
One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes (1974) 1.02
The islet in type 2 diabetes: back to center stage. Diabetes (2001) 1.01
Haemoglobinopathies: a pitfall in the assessment of glycosylated haemoglobin by ion-exchange chromatography. Diabetologia (1984) 1.01
Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia (1981) 0.99
Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes (1982) 0.99
[Human renal homotransplantation. Personal results in 52 patients. I. Technics and over-all results]. Presse Med (1965) 0.98
T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes. J Clin Immunol (1999) 0.98
Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochem J (1992) 0.97
Characterization of a purified glycoprotein from Schistosoma mansoni eggs: specificity, stability, and the involvement of carbohydrate and peptide moieties in its serologic activity. J Immunol (1982) 0.96
Anti-islet immunity and thymic dysfunction in the mutant diabetic C57BL/KsJ db/db mouse. Diabetes (1983) 0.96
Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. Genomics (2001) 0.96
Macrophage cytotoxicity in the mouse immune response against a skin allograft. J Immunol (1975) 0.96
Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus. Concepts Immunopathol (1986) 0.96
Plasma glucagon, thyrotropin, growth hormone and insulin response to cold exposure in the human newborn. Acta Paediatr Scand (1972) 0.96
High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J Autoimmun (1997) 0.95
Glucagon antibodies. Lancet (1965) 0.95
Breast inflammatory gigantomastia in a context of immune-mediated diseases. J Clin Endocrinol Metab (2005) 0.95
Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice. Eur J Immunol (1989) 0.94
A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes (2001) 0.94
Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am J Physiol (1993) 0.93
Phenformin-induced lactic acidosis in diabetic patients. Diabetes (1975) 0.93
Orofacial radiological manifestations of systemic sclerosis. Dentomaxillofac Radiol (1996) 0.93
Evidence for the presence of insulin-dependent diabetes-associated alleles on the distal part of mouse chromosome 6. Genome Res (1998) 0.92
Proteinuria in patients with homotransplanted kidneys. Nature (1966) 0.92
Insulin autoantibodies in non-obese diabetic (NOD) mice. Clin Exp Immunol (1989) 0.92
Heterogeneity of fetal growth in type 1 diabetic pregnancy. Diabetes Metab (2001) 0.92
Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus. J Virol (1989) 0.92
Prostaglandin (PG) release in the mixed lymphocyte culture; effect of presensitization by a skin allograft; nature of the PG-producing cell. Eur J Immunol (1980) 0.92
Collection of lymph from kidneys homotransplanted in man: cell transformation in vivo. Nature (1971) 0.92
Glycopeptides in soluble egg antigen of Schistosoma mansoni: isolation, characterization, and elucidation of their immunochemical and immunopathological relation to the major egg glycoprotein (MEG). J Immunol (1985) 0.91
Schistoma mansoni soluble egg antigens: determination of the stage and species specificity of their serologic reactivity by radioimmunoassay. J Immunol (1976) 0.91
Overwhelming strongyloidiasis in a diabetic patient following ACTH treatment and keto-acidosis. Diabete Metab (1988) 0.91
[Human renal homotransplantation. Personal results in 52 patients. 3. Extra-renal complications--general conclusions]. Presse Med (1965) 0.91
Multiple DNA variant association analysis: application to the insulin gene region in type I diabetes. Am J Hum Genet (1994) 0.90
What ails the β-cell? Diabetes Obes Metab (2010) 0.90